Why should Australia adopt universal infant hepatitis B vaccination?

Australian and New Zealand Journal of Public Health

Volumn 20, Issue 4, 1996, Pages 436-439

  Thompson, Sandra ^a  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; HEALTH CARE POLICY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; SHORT SURVEY; VACCINATION;

EID: 0029848383     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1996.tb01061.x     Document Type: Short Survey

References (49)

1. Henderson RH. Vaccination: successes and challenges. In: Cutts FT, Smith PG, editors. Vaccination and world health. London School of Hygiene and Tropical Medicine, Fourth annual public health forum. Chichester, UK: Wiley, 1994.
2. Maynard JE. Hepatitis B: global importance and need for control. Vacine 1990; 8(suppl): S18-20.
3. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991; 11: 84-92.
4. McMahon BJ, Alward WLM, Hall DB, et al Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
5. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981; 2: 1129-33.
6. World Health Organization. Thirteenth meeting of Global Advisory Group of EPI. Weekly Epidemiol Rec 1992; 3: 9-12.
7. Thompson SC, Ruff TA. Hepatitis B vaccination: what are the current international recommendations? Clin Immunother 1995; 3: 15-26.
8. National Health and Medical Research Council. Australian immunisation procedures handbook. Canberra: NHMRC. 1994.
9. Radvan GH, Allworth AM, Fardv GL, Keller AJ. Hepatitis B markers in health care workers. The Newcastle study. Med J Aust 1984; 140: 583-5.
10. Anderson B, Bodsworth NJ, Rohrsheim RA, Donovan BJ. Hepatitis B virus infection and vaccination status of high risk people in Sydney: 1982-1991. Med J Aust 1994; 161: 368-71.
11. Dwyer R, van Beek I, Pethebridge A, Kaldor J. HBV immunisation among people who inject drugs [abstract]. Immunisation: putting the jigsaw together. Canberra: Public Health Association, March 1995.
12. Alter MJ, Hadler SC, Margolis HS, Alexander T, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990; 263: 1218-22.
13. Bhatti N, Gilson RJC, Beecham M, Williams P, et al. Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ 1991; 303: 97-101.
14. Alter MJ. Community acquired viral hepatitis B and C in the United States. Gut 1993; 34(2 suppl): S17-19.
15. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood immunization: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40(RR-13): 1-25
16. Smith CP, Perle M, Morris DJ. Implementation of government recommendations for immunising infants at risk of hepatitis B. BMJ 1994; 309: 1339
17. Combined active-passive surveillance of acute hepatitis B [editorial comment]. Comm Dis Intell 1995; 19: 258-60
18. Surveillance of sexually transmitted diseases in Victoria, 1990. Melbourne: AIDS/STD Unit, Health Department Victoria, 1991-1994.
19. National Health and Medical Research Council. Antenatal care. Report of the 106th session, Canberra, November 1988, Canberra: NHMRC, 1989.
20. Rushworth RL, Bell SM, Rob MI, Taylor PT. Diagnostic testing during pregnancy: a descriptive analysis of utilisation data. Aust J Public Health 1994; 18: 401-6.
21. Oman K, Ruff T, Carnie J. Hepatius B immunisation rates among high risk infants in Victoria [abstract]. Immunisation: putting the jigsaw together. Canberra: Public Health Association, 1995.
22. Resnick RB. A hepatitis B vaccination programme for inner metropolitan Sydney neonates. Med J Aust 1991; 155: 153-6.
23. Riley R, Maher C, Kolbe A. Hepatitis B vaccination of high-risk neonates in the south west region of New South Wales: evaluation of the program coverage. Aust J Public Health 1993; 17: 171-3
24. Jayaram S. Neonatal hepatitis B vaccination program. Public Health Bull (Sydney) 1992; 3: 27-8.
25. Position statement: hepatitis B. Sydney: Royal Australian College of General Practitioners, 1994.
26. Australian Gastroenterology Institute. Hepatitis B ... an information booklet for healthcare providers. Sydney: Gastroenterology Society of Australia, 1995
27. Thompson SC, Stevenson E, Wilby R, Crofts N. Hepatitis B infection in Victoria 1992: time to review the high-risk strategy [letter]. Med J Aust 1993; 159: 562-3
28. Crofts N, Stewart T, Hearne P, Ping XY, et al. Spread of blood-borne viruses among prison entrants in Victoria. BMJ 1995; 310: 285-8.
29. Milne A, Hopkirk N, Moves CD. Hepatitis B vaccination in children: persistence immunity at 9 years. J Med Virol 1994; 44: 113-14.
30. West DJ, Watson B, Lichtman J, Hesley TM, Hedberg K. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy: Pediatr Infect DisJ 1994; 13: 745-7.
31. Plaitano S, Sagliocca L, Mele A, Bove C, et al. Hepatitis B mass immunization of adolescents: a pilot study in a community Eur J Epidemiol 1993; 9: 307-10.
32. Centers for Disease Control. Hepatitis B vaccination of adolescents: California, Louisiana, and Oregon, 1992-1994. MMWR 1994; 43: 605-9.
33. Wong VK, Woodruff C, Shapiro R. Compliance of hepatitis B vaccination in patients presenting to a teenage clinic. Pediatr Infect Dis J 1994; 13: 936.
34. Douglas RG. The children's vaccine initiative - will it work? J Inject Dis 1993; 168: 269-74.
35. Butler J. Cost-effectiveness of four alternative programs for the immunisation of infants and pre-adolescents against hepatitis B in Australia. Working paper for NHMRC Panel on hepatitis B. Canberra: National Health and Medical Research Council, 1985.
36. Gross PF, Tiffin A. The economic costs of hepatitis B in Australia, 1990: mass vaccination and other strategies. Health Economics and Technology Assessment Corporation, Sydney, 1990. Health Economics Monograph No 38.
37. Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986; 315: 209-14.
38. Wainwright RB, McMahon BJ, Bulkow LR. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA 1989; 261: 2362-6.
39. Steven CE, Toy PT, Taylor PE, Lee T, Yip HY. Prospects for control of hepatitis B virus infection: implications of childhood infections and long-term protection. Pediatrics 1992; 90: 170-3.
40. Coursaget P, Leboullex D, Soumare M, le Cann P, et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 1994; 21. 250-4.
41. Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994, 140: 734-46.
42. Goldwater PN. History of hepatitis B vaccination in New Zealand: lessons for Australia? Aust J Public Health 1993; 17: 221-5.
43. Williams SJ, Batey RG, Craig PI, Farrell GC, Liddle C. Hepatitis B in Australia: determinants of intrafamily spread. Aust NZ Med J 1987; 17: 220-7.
44. Campbell DH, Plant AJ, Sargent JW, Mock PA, et al. Hepatitis B infection in children in a mixed-race community in western New South Wales. MedJ Aust 1991; 154: 253-6.
45. Gardner ID, Wan X, Simms PA, Worswick DA, et al. Hepatitis B virus markers in children and staff in Northern Territory schools. Med J Aust 1992; 156: 638-41.
46. Gill JS, Hatton M, Carey M, Quadros CF Markers of hepatitis B virus infections in schoolchildren in the Kimberley, Western Australia. MedJ Aust 1990; 153: 34-7.
47. Burgess MA, McIntosh DG, Allars HM, Kendrick KG. Hepatitis B in urban Australian school children. No evidence of horizontal transmission between high-risk and low-risk groups. Med J Aust 1993; 159: 315-19.
48. Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989; 2: 889-93.
49. Halsey NA. Discussion of Immunization Practices Advisory Committee/American Academy of Pediatrics recommendations for universal infant hepatitis B vaccination. Pediatr Infect Dis J 1993; 12: 446-9.